RBC Raises Chemed Price Target to $585 From $548
RBC kept its Sector Perform rating on Chemed.
Related stories
Canada Takes Stake in Cohere as Cohere Opens a Funding Round
The Canadian government acquired a stake in Cohere as the AI company opened a funding round.
L impact | EQUITY | Oct 29, 2026, 04:22 PM UTC
Ottawa Acquires Stake in Cohere as AI Firm Starts a Funding Round
The Canadian government acquired a stake in Cohere as the AI company began a funding round.
M impact | EQUITY | Oct 29, 2026, 04:22 PM UTC
Microsoft Expects to Raise About $25 Billion in U.S. Bond Sale
Microsoft expects to raise about $25 billion through a U.S. bond sale, according to a source.
M impact | EQUITY | Oct 29, 2026, 04:20 PM UTC
NYSE Halt Adds Information on LST at $5.80
L impact | EQUITY | Oct 29, 2026, 04:17 PM UTC
Viridian Metals Plans Private Placement of Up to CA$5 Million
Viridian Metals plans to raise up to CA$5 million through a private placement of units.
L impact | EQUITY | Oct 29, 2026, 04:16 PM UTC
Waterland to Acquire 50% Stake in Milieu Service Groep
Waterland Private Equity agreed to acquire a 50% stake in Milieu Service Groep.
M impact | EQUITY | Oct 29, 2026, 04:14 PM UTC